Presence of DNA of Human Papillomavirus 16 but No Other Types in Tumor-Free Tonsillar Tissue

ABSTRACT According to PCR, the prevalences of human papillomavirus (HPV) DNA were 6.3% (13 of 206) in tonsillitis or hypertrophic tonsillar tissues and 0.6% (1 of 174) in exfoliated cells from normal tonsils. HPV-16 was the only type detected in tonsillar tissues, but it did not appear to lead to L1 antibody production.

[1]  S. Syrjänen.  Human papillomavirus (HPV) in head and neck cancer. , 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[2]  S. Syrjänen.  HPV infections and tonsillar carcinoma , 2004, Journal of Clinical Pathology.

[3]  L. Turek,et al.  Human Papillomavirus in Oral Exfoliated Cells and Risk of Head and Neck Cancer , 2004 .

[4]  L. Turek,et al.  Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. , 2003, Journal of the National Cancer Institute.

[5]  S. Watanabe,et al.  Human papillomavirus type 16 DNA detected by the polymerase chain reaction in non-cancer tissues of the head and neck , 2004, European Archives of Oto-Rhino-Laryngology.

[6]  S. Watanabe,et al.  Comparison of Virapap filter hybridization with polymerase chain reaction and Southern blot hybridization methods for detection of human papillomavirus in tonsillar and pharyngeal cancers , 2004, European Archives of Oto-Rhino-Laryngology.

[7]  S. Franceschi,et al.  Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. , 2003, Journal of the National Cancer Institute.

[8]  W. Quint,et al.  Prevalence and physical status of human papillomavirus in squamous cell carcinomas of the head and neck , 2003, International journal of cancer.

[9]  M. Pawlita,et al.  HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase. , 2002, Journal of virological methods.

[10]  A. Weaver,et al.  Squamous cell carcinoma of the tonsils: a molecular analysis of HPV associations. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[11]  H. Dienes,et al.  Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas , 2001, Cancer.

[12]  P. Fuchs,et al.  Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. , 2001, The New England journal of medicine.

[13]  M. Pawlita,et al.  A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology. , 2001, Journal of immunological methods.

[14]  K. Shah,et al.  Human papillomavirus–associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers , 2001, Current opinion in oncology.

[15]  R. Lewensohn,et al.  Human papillomavirus (HPV) DNA in tonsillar cancer: Clinical correlates, risk of relapse, and survival , 2000, International journal of cancer.

[16]  H. Tideman.  An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring , 1999 .

[17]  J. Dillner,et al.  Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16. , 1999, The Journal of general virology.

[18]  M. Sapp,et al.  Prevalence of antibodies to human papillomaviruses in the general population of the Czech Republic , 1998, International journal of cancer.

[19]  K. Shah,et al.  Antibodies to human papillomavirus 16 and subsequent in situ or invasive cancer of the cervix. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[20]  冨永 進.  Presence of Human Papillomavirus Type 6f in Tonsillar Condyloma Acuminatum and Clinically Normal Tonsillar Mucosa , 1997 .

[21]  Y. Masuda,et al.  Presence of human papillomavirus type 6f in tonsillar condyloma acuminatum and clinically normal tonsillar mucosa. , 1996, Japanese journal of clinical oncology.

[22]  C. Meijer,et al.  The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. , 1995, The Journal of general virology.

[23]  S. Gray,et al.  Human papillomavirus infection in papillomas and nondiseased respiratory sites of patients with recurrent respiratory papillomatosis using the polymerase chain reaction. , 1993, Archives of otolaryngology--head & neck surgery.

[24]  G. Snow,et al.  Prevalence and expression of human papillomavirus in tonsillar carcinomas, indicating a possible viral etiology , 1992, International journal of cancer.

[25]  C. Meijer,et al.  Human papillomavirus type 33 in a tonsillar carcinoma generates its putative E7 mRNA via two E6* transcript species which are terminated at different early region poly(A) sites , 1992, Journal of virology.

[26]  H. Stein,et al.  Detection of human papillomavirus type 16 DNA in carcinomas of the palatine tonsil. , 1990, Journal of clinical pathology.

[27]  H. Fox,et al.  Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. , 1990, Journal of the National Cancer Institute.

[28]  J. Brandsma,et al.  Association of papillomavirus with cancers of the head and neck. , 1989, Archives of otolaryngology--head & neck surgery.

[29]  K. Mullis,et al.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. , 1985, Science.